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Abstract—The recent introduction of advanced magnetic resonance (MR) imaging techniques to characterize
focal and global degeneration in multiple sclerosis (MS), like the Composite Hindered and Restricted Model of Dif-
fusion, or CHARMED, diﬀusional kurtosis imaging (DKI) and Neurite Orientation Dispersion and Density Imaging
(NODDI) made available new tools to image axonal pathology non-invasively in vivo. These methods already
showed greater sensitivity and speciﬁcity compared to conventional diﬀusion tensor-based metrics (e.g., frac-
tional anisotropy), overcoming some of its limitations. While previous studies uncovered global and focal axo-
nal degeneration in MS patients compared to healthy controls, here our aim is to investigate and compare
diﬀerent diﬀusion MRI acquisition protocols in their ability to highlight microstructural diﬀerences between MS
and control tissue over several much used models. For comparison, we contrasted the ability of fractional aniso-
tropy measurements to uncover diﬀerences between lesion, normal-appearing white matter (WM), gray matter and
healthy tissue under the same imaging protocols. We show that: (1) focal and diﬀuse diﬀerences in several
microstructural parameters are observed under clinical settings; (2) advanced models (CHARMED, DKI and
NODDI) have increased speciﬁcity and sensitivity to neurodegeneration when compared to fractional anisotropy
measurements; and (3) both high (3 T) and ultra-high ﬁelds (7 T) are viable options for imaging tissue change in
MS lesions and normal appearing WM, while higher b-values are less beneﬁcial under the tested short-time
(10 min acquisition) conditions.
This article is part of a Special Issue entitled: MRI and Neuroinflammation.  2018 The Author(s). Published by Elsevier Ltd on
behalf of IBRO. This is an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Multiple sclerosis (MS) is a human neurological disorder
with an onset most often in young adulthood that aﬀects
almost 2.5 million individuals worldwide, involving focal
demyelination and axonal loss (Weinshenker, 1996;https://doi.org/10.1016/j.neuroscience.2018.03.048
0306-4522/ 2018 The Author(s). Published by Elsevier Ltd on behalf of IBRO.
This is an open access article under the CC BY-NC-ND license (http://creativecomm
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Abbreviations: CHARMED, Composite Hindered and Restricted Model
of Diﬀusion; DIR, Double Inversion Recovery; DTI, diﬀusion tensor
imaging; FA, fractional anisotropy; FLAIR, ﬂuid-attenuated inversion
recovery; FR, restricted fraction; GM, gray matter; GRAPPA,
generalized autocalibrating partial parallel acquisition; MK, mean
kurtosis; MP2RAGE, magnetization-prepared two rapid acquisition
gradient-echoes; MPRAGE, magnetization-prepared rapid gradient-
echo; MRI, magnetic resonance imaging; MS, multiple sclerosis;
NAGM, normal appearing gray matter; NAWM, normal appearing
white matter; ODI, orientation dispersion index; WM, white matter.
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https://doi.org/10.1016/j.neuroscience.2018.03.048Noseworthy et al., 2000; Ellwardt and Zipp, 2014). With
its ability to image soft tissues in vivo noninvasively, diﬀu-
sion tensor imaging (DTI; Basser et al., 1994) has shown
high sensitivity in detecting brain damage in MS. Using
DTI, abnormalities in diﬀusivity patterns have been
detected in focal MS lesions, normal-appearing white
matter (NAWM) and gray matter (GM) (Werring et al.,
1999; Vrenken et al., 2006). However, DTI-derived scalar
indices such as fractional anisotropy (FA) (Basser and
Pierpaoli, 1996) lack speciﬁcity to diﬀerent sub-
compartments of white matter (WM) microstructure: in
the context of MS, both demyelination and axonal loss
have similar impact on DTI indices and can therefore
not be diﬀerentiated using this technique (Wheeler-
Kingshott and Cercignani, 2011). In addition, it was
recently shown that DTI accuracy is strongly aﬀected byons.org/licenses/by-nc-nd/4.0/).
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interpret and merge data coming from diﬀerent centers
(Barrio-Arranz et al., 2015).
In the last few years, several advanced diﬀusion-
weighted imaging methods have been introduced to
overcome these limitations. Diﬀusional Kurtosis Imaging
(DKI) quantiﬁes the deviation of the MRI signal decay
from the DTI exponential model using a dimensionless
metric called the excess kurtosis (Jensen et al., 2005).
Recent evidence suggests that DKI indices like the mean
kurtosis are aﬀected in MS compared to controls
(Guglielmetti et al., 2016). Moreover, signiﬁcant correla-
tions between DKI parameters and the Expanded Disabil-
ity Status Scale were also reported (de Kouchkovsky
et al., 2016). The Composite Hindered and Restricted
Model of Diﬀusion (CHARMED) (Assaf et al., 2004) sepa-
rates the contributions of diﬀerent intra- and extracellular
water compartments to the signal decay measured in
diﬀusion-weighted imaging, and can therefore be used
to extract new biomarkers of tissue microstructure which
are able to disentangle the eﬀects of axonal loss from
those due to demyelination (Assaf et al., 2004).
CHARMED generates maps of the restricted water frac-
tion (FR), a proxy for the axonal density, which was
recently shown to provide increased speciﬁcity and sensi-
tivity to microstructural changes happening in early MS,
both in lesions and in NAWM (De Santis et al., 2017).
Along the same lines, Neurite Orientation Dispersion
and Density Imaging (NODDI; Zhang et al., 2012) pro-
vides, in addition to the restricted water fraction, an index
quantifying the ﬁber dispersion. A few recent studies used
the NODDI model to investigate GM (Granberg et al.,
2017), spinal cord (By et al., 2017) and WM (Granberg
et al., 2017; Schneider et al., 2017), reporting an increase
in both sensitivity and speciﬁcity in diﬀerentiating patients
from controls.
The acquisition time for these advanced diﬀusion-
weighted imaging methods is typically longer than for
DTI, as they require the diﬀusion images to be acquired
along many diﬀerent gradient orientations and for at
least two diﬀerent b-values (Chuhutin et al., 2017;
Zhang et al., 2012; De Santis et al., 2014), i.e., they need
a multi-shell diﬀusion MRI acquisition. The majority of the
mentioned studies were performed using advanced gradi-
ent equipment (i.e., maximum gradient intensity of 300
mT/m, De Santis et al., 2017); the same protocols imple-
mented on scanners mounting conventional gradient
equipment (40–80 mT/m) would result in acquisition times
too long for the clinical setting to be feasible, and a drop in
the signal-to-noise ratio. The remaining challenge for
translation to clinics at 3 T, and for inclusion into
advanced pipelines at 7 T, is to be able to measure these
microstructural changes under more conventional gradi-
ent settings.Table 1. Participants’ demographic and clinical characteristics: mean numb
Abbreviations: MS = Multiple sclerosis; SD = Standard deviation; EDSS = E
Mean age (SD) Mean n of lesions
Healthy 42 (15) y –
MS 42 (15) y 8.3 ± 6.5
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https://doi.org/10.1016/j.neuroscience.2018.03.048Employing an eﬃcient pipeline is extremely important
because it dramatically aﬀects the accuracy and precision
of the measured biomarkers. In the context of MS,
improved accuracy and precision can potentially
uncover early tissue changes invisible to conventional
approaches. In addition, an optimal scheme can reduce
the acquisition time, which is critical for ensuring
feasibility of advanced diﬀusion MRI methods in clinical
studies, possibly also in a multi-center design and,
ultimately, to pave the way for their inclusion into clinical
routine. However, this theme is often disregarded due to
the high complexity of the model parameters
optimization; a few studies have proposed optimal
experimental designs for multi-shell techniques
(Alexander et al., 2010; Prcˇkovska et al., 2012; Zhang
et al., 2012; De Santis et al., 2014; Chuhutin et al.,
2017), but these were not yet applied to MS patient stud-
ies. In addition, the diﬀerential ability of various diﬀusion-
based imaging biomarkers to highlight microstructural
abnormalities present in MS tissue compared to healthy
controls has not yet been investigated.
Here, we employed two optimized multi-shell diﬀusion
protocols at two diﬀerent ﬁelds (7 T vs. 3 T) to measure
several MRI biomarkers in a cohort of MS patients and
a matched cohort of healthy controls, with the aim of
identifying the protocol that best distinguishes tissue
diﬀerences in lesions, NAWM and normal appearing
gray matter (NAGM) compared to healthy controls. For
the CHARMED model, the only tested model for which
very high (>3000 s/mm2) b-values can be beneﬁcial,
two diﬀerent acquisition protocols proposed in recent
literature, at low (Zhang et al., 2012) and very high b-
value (De Santis et al., 2014), were also tested.
This work is expected to impact future choices for
investigating MS WM microstructure in larger cohorts,
follow-ups or focusing on speciﬁc stages of the disease,
and for selecting the appropriate experimental
framework to obtain optimal data quality for the
allocated time.EXPERIMENTAL PROCEDURES
Data acquisition
Seven MS patients and six age-matched healthy controls
underwent a comprehensive MRI protocol in two diﬀerent
sessions, scheduled no more than 48 h apart. All MS
patients were in the early phase of the disease (duration
3 years) and had been diagnosed with relapsing-
remitting MS. At the time of scanning, three were
receiving medical treatment with interferon beta-1a, two
with natalizumab, one with mitoxantrone and one with
glatiramer acetate. Participants’ demographic and
clinical characteristics are reported in Table 1.er of lesions, mean disease duration in years and median EDSS.
xpanded Disability Status Scale
Mean disease duration (months) Median EDSS
– –
21 ± 11 1 (range 0–3)
lerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
Fig. 1. Boxplot of SNR of the b0 image (unweighted scan) for the
three diﬀerent tested protocols, separated for the healthy control
group and the MS patients. The bottom and top of the box are ﬁrst
and third quartiles, and the thick band inside the box is the median.
Whiskers represent maximum and minimum of all data. Asterisks
represent signiﬁcant diﬀerence in the t-test statistic (** = P< 0.01).
Abbreviations: HC = Healthy controls, MS = Multiple sclerosis;
SNR = Signal-to-noise ratio.
S. De Santis et al. / Neuroscience xxx (2018) xxx–xxx 3The ﬁrst scan session was acquired on a 3 T Siemens
PrismaFIT scanner and comprised: an anatomical
magnetization-prepared rapid gradient-echo (MPRAGE)
scan, resolution 1 mm isotropic, TE/TR 2/2250 ms; a
multi-shell diﬀusion protocol with b= 700/2000 s/mm2
and 27/45 gradient orientations according to Zhang
et al. (2012), plus two unweighted scans with forward
phase encoding and six unweighted scans with reversed
phase encoding, at 1.5-mm isotropic resolution, TE/TR
68/4873 ms, scan duration 8 min; and another multi-
shell diﬀusion protocol with maximum b = 6000 s/mm2,
106 unique gradient orientations distributed in eight shells
of b-value between 750 and 6000 s/mm2 according to De
Santis et al. (2014), plus six unweighted scans with for-
ward phase encoding and six unweighted scans with
reversed phase encoding, at 1.5-mm isotropic resolution,
TE/TR 94/6000 ms, scan duration 12 min. The Simultane-
ous multislice or Multiband (MB) acceleration technique
(Setsompop et al., 2012), implemented in the Center for
Magnetic Resonance Research (CMRR) (https://www.
cmrr.umn.edu/multiband/), was used for all diﬀusion pro-
tocols with multiband factor 2 and generalized autocali-
brating partial parallel acquisition (GRAPPA) factor 2
(Moeller et al., 2010; Xu et al., 2013). Throughout this
work, the ﬁrst multi-shell protocol will be addressed as
‘‘low-b protocol” while the second multi-shell protocol will
be addressed as ‘‘high-b protocol”. Total acquisition time
was around 30 min.
The second session was acquired on a 7 T Magnetom
Siemens scanner. To minimize the eﬀects of B1
inhomogeneity, dielectric pads (Teeuwisse et al., 2012)
were placed between the subject’s head and the coil,
positioned in correspondence with temporal and occipital
lobes, i.e., the brain areas most aﬀected by such inhomo-
geneity in a volume transmit coil. The session comprised:
an anatomical MP2RAGE scan, resolution 0.7 mm isotro-
pic, TE/TR 2.47/5000 ms, scan duration 10 min; a multi-
shell diﬀusion with b= 700/2000 s/mm2 and 27/45 gradi-
ent orientations, plus two unweighted scans with forward
phase encoding and six unweighted scans with reversed
phase orientation, at 1.5-mm isotropic resolution, TE/TR
60/7500 ms, scan duration 10 min; a WM Double
Inversion Recovery (DIR; Pracht et al., 2017) scan with
resolution 1 mm isotropic, TE/TR 163/3000, scan duration
8 min; a GM DIR scan with resolution 1 mm isotropic, TE/
TR 163/3000, scan duration 8 min. GRAPPA was used
with factor 2. Total acquisition time, comprising also
adjustment time, was around one hour. Due to the need
to keep the examination time within one hour, and
because of the higher penalty of long-TE high b-value
diﬀusion scan (the relaxation time T2 is shorter at higher
ﬁelds) it was not possible to acquire a high-b diﬀusion
protocol at 7 T.
Data processing and normalization
Diﬀusion data were pre-processed using FSL TOPUP and
EDDY (Andersson et al., 2003; Andersson and
Sotiropoulos, 2016) to correct for susceptibility-induced
distortions, eddy currents and subject motion. Signal-to-
Noise Ratio (SNR) values in the b0 images were calcu-
lated for each diﬀusion protocol in the whole brain usingPlease cite this article in press as: De Santis S et al. Characterizing Microstructural Tissue Properties in Multiple Sc
https://doi.org/10.1016/j.neuroscience.2018.03.048the diﬀerence method (Murphy et al., 1993), returning:
SNR = 20.6 ± 2.2 for 3 T/low-b protocol, SNR = 15.1
± 2.3 for 7 T/low-b protocol and SNR = 16.9 ± 1.7 for
3 T/high-b protocol. Boxplots of SNRs for the diﬀerent
protocols are shown in Fig. 1.
Conventional DTI data analysis was performed with
the ExploreDTI software (Leemans et al., 2009) using
only the b= 700 s/mm2 shell; from the tensor, maps of
FA were obtained. Only low-b protocols were used to
estimate FA, since the DTI model is not appropriate for
b-values >1500 s/mm2 (Jones et al., 1999).
Subsequently, all diﬀusion data at both ﬁelds was
employed for multi-shell diﬀusion analysis. The kurtosis
model was ﬁtted using FSL’s FDT (Jenkinson et al.,
2012) to obtain the mean kurtosis (MK), while NODDI
maps of restricted volume fraction (FRNODDI) and
orientation dispersion (ODI) were ﬁtted using the
software MDT (https://github.com/cbclab/MDT, version
0.10.6) using the Cascade Initialized optimization
strategy (Harms et al., 2017). The CHARMED model
was ﬁtted using in-house software written in Matlab
R2015b (The Mathworks). The CHARMED ﬁtting proce-
dure was based on nonlinear least square estimation
using a Levenberg-Marquardt optimization. After ﬁtting
the CHARMED model, maps of the restricted volume
fraction (FRCHARMED) were computed for each subject
under all the tested conditions: 3 T/low-b, 3 T/high-b and
7 T/low-b.
In the MS group, lesions were segmented manually
and carefully checked by a trained radiologist using the
two DIR images at 7 T, where the lesions are hyper-
intense in the GM-DIR and hypo-intense in the
WM-DIR, as shown in Fig. 2. Lesions were only scored
above 3 voxels in size based on at least 1 mm2lerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
Fig. 2. Lesion mask on WM DIR (a) and GM DIR (b) maps. The lesion (circled in red) appears as a region of hypo-intensity in the WM DIR and
hyper-intensity in the GM DIR. In panels (c) and (d), the lesion mask is shown. (e) Schematic of the registration procedure which brings lesion mask
in diﬀusion space. (f) Example of microstructural maps employed in this study. Abbreviations: WM=White matter, DIR = Double Inversion
Recovery; GM= Gray matter; FA = Fractional anisotropy; MK = Mean Kurtosis; FR = Restricted fraction; NODDI = Neurite orientation
dispersion and density imaging; ODI = Orientation Dispersion Index; CHARMED= Composite hindered and restricted model of diﬀusion.
4 S. De Santis et al. / Neuroscience xxx (2018) xxx–xxxin-plane resolution, according to recent consensus
recommendations (Geurts et al., 2011), but lesions smal-
ler than 12 voxels in volume were not taken into account
in the statistics, in order to forego possible co-registration
inaccuracies. The lesion masks were then transferred into
the diﬀusion space according to the following procedure:
the WM DIR maps were registered to the MPRAGE maps
(for 3 T) or to the MP2RAGE maps (for 7 T); then, the dif-
fusion unweighted scans (i.e., b0s) were registered to the
MPRAGE and MP2RAGE anatomical scans, and the
inverse transformation was calculated. All the transforma-
tions employed at this stage were rigid body (6 degrees of
freedom); the cost function chosen was the Correlation
Ratio and all the brains were extracted using FSL BET
software (Jenkinson and Smith, 2001) prior to registra-
tion. The two transformations were combined and applied
to the lesion masks. All the aforementioned registration
steps were performed using FSL FLIRT software
(Jenkinson and Smith, 2001); the registration pipeline is
illustrated in Fig. 2e.
All FA maps were then nonlinearly warped to the
FMRIB58 FA template using ANTs (Klein et al., 2009).
Importantly, the co-registration procedure excludes lesion
masks from the computation of the ﬁgure of merit
employed in the optimization procedure that calculates
warp ﬁelds, so that the normalization is accurate also
for MS subjects. The same transformation was applied
to all the other biomarkers (MK, FRNODDI, ODI,
FRCHARMED) and to the lesion masks.Please cite this article in press as: De Santis S et al. Characterizing Microstructural Tissue Properties in Multiple Sc
https://doi.org/10.1016/j.neuroscience.2018.03.048To compare NAWM in MS patients and controls, the
WM skeleton was calculated using parts of the TBSS
pipeline (Smith et al., 2006) combined with an automatic
ROI (region of interest) selection using WM labeling in
standard space (JHU ICBM DTI 81 Atlas, also available
in FSL), a procedure described previously (De Santis
et al., 2012). To compare NAGM between MS patients
and controls, a similar approach was employed using
the GM parcellation in Brodmann areas available in
ExploreDTI (Leemans et al., 2009).
Mean values and standard deviations were calculated
for each parameter (MK, FRNODDI, ODI, FRCHARMED) and
each protocol (3 T/low-b, 3 T/high-b and 7 T/low-b) in the
following regions: (1) in each ROI belonging to the WM
skeleton for controls and MS (in MS, lesions were
excluded); (2) in each ROI belonging to the GM
parcellation for controls and MS (in MS, lesions were
excluded); and 3) in each lesion from the masks for MS
patients and in the corresponding registered ROI from
healthy controls.Statistical analysis
Analysis of variance (ANOVA) was used to assess
whether the applied protocol had a signiﬁcant eﬀect on
the measured parameters. Within-subject eﬀect was the
protocol (3 T and 7 T for FA, MK, FRNODDI, ODI and 3 T/
low-b, 3 T/high-b and 7 T/low-b for FRCHARMED) and
between-subject eﬀect was the tissue kind (healthy,lerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
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of no interest in the analysis.
Given that diﬀerent anatomical locations present
diﬀerent baseline values for each parameter, in order to
render diﬀerences between MS lesions and
corresponding ROIs in healthy controls comparable, we
calculated the diﬀerence between the two values and
divided it by the reference value in healthy controls,
according to the following formula:in
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9where P is the parameter (FA, MK, FRNODDI, ODI,
FRCHARMED in this study). The null hypothesis of no
diﬀerence between lesions and healthy tissue was
then tested across patients through a nonparametric
signed-rank test. Likewise, the group eﬀect was tested
in 50 ROIs from the JHU ICBM DTI 81 atlas (Mori
et al., 2008), projected onto the WM skeleton, using a
nonparametric signed-rank test, and on 41 Brodmann
areas in GM. The eﬀect size was calculated as the dif-
ference between the biomarker values in the MS group
and in the healthy control group, divided by the pooled
standard deviation (Cohen’s d). Post-hoc comparisons
between groups were performed using the Mann–
Whitney test, under the assumption that the presence
of the disease causes a decrease in the measured
imaging parameters (left tail only). Multiple comparisons
were corrected for the false discovery rate (Benjamini
and Yekutieli, 2005). All statistical analysis was per-
formed with SPSS software (IBM SPSS Statistics for
Mac, Version 23.0) and Matlab. P-values below 0.05
were considered signiﬁcant.s
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Mean biomarker values and ANOVA
Mean values and standard deviations for the investigated
biomarkers, in the whole WM skeleton, in the GM areas
and in the lesion masks, are reported in Table 2.
In Table 3, the results of the ANOVA show that there
is a signiﬁcant eﬀect of the type of tissue (lesion in MS,
NAWM and WM in healthy controls) for all parameters,
while the protocol has a signiﬁcant eﬀect for FA,
FRNODDI and FRCHARMED. The interaction between the
two factors is signiﬁcant for FA and FRCHARMED.T
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0Diﬀerences between MS lesions and healthy control
tissue
Fig. 3 shows the values of FA, MK, FRNODDI, ODI and
FRCHARMED in lesions and in the corresponding healthy
tissue in the control cohort across the diﬀerent tested
protocols; in the boxplot, the reported statistic indicates
signiﬁcant diﬀerences between the two cohorts in the
nonparametric signed-rank test. All indices show
signiﬁcant diﬀerences for both tested protocols. Lesions,
as expected, are characterized by higher standard
deviation compared to control values.Please cite this article in press as: De Santis S et al. Characterizing Microstructural Tissue Properties in Multiple Sclerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
https://doi.org/10.1016/j.neuroscience.2018.03.048
Fig. 3. In the top row, microstructural parameter values for healthy controls vs lesions measured at 3 T: FA (a), MK (b), FR from NODDI (c), ODI (d),
FR from CHARMED (e) and FR from CHARMED measured with the high-b protocol (f). In the bottom row, microstructural parameter values for
healthy controls vs lesions measured at 7 T: FA (g), MK (h), FR from NODDI (i), ODI (j), FR from CHARMED (k). Asterisks represent signiﬁcant
diﬀerence in the nonparametric signed-rank test statistic (** = P< 0.01). In (l), an example of lesion mask. Abbreviations: FA = Fractional
anisotropy; MK = Mean Kurtosis; FR = Restricted fraction; NODDI = Neurite orientation dispersion and density imaging; ODI = Orientation
Dispersion Index; CHARMED= Composite hindered and restricted model of diﬀusion; HC = Healthy controls.
Table 3. ANOVA results (F statistics and corresponding P-values) showing the eﬀects of the protocol, of the tissue type, and of their interaction, on the
measured biomarkers. Abbreviations: ANOVA = Analysis of variance, FA = Fractional anisotropy; MK = Mean Kurtosis; FR = Restricted fraction;
NODDI = Neurite orientation dispersion and density imaging; ODI = Orientation Dispersion Index; CHARMED = Composite hindered and restricted
model of diﬀusion
FA MK FRNODDI ODI FRCHARMED
F p-value F p-value F p-value F p-value F p-value
Protocol 11.6 <0.01** 0.057 n.s. 5.1 <0.05* 0.1 n.s. 5.3 <0.05*
Tissue 125.8 <0.01** 46.3 <0.01** 16.3 <0.01** 83.8 <0.01** 9.4 <0.01**
Interaction 4.5 <0.01** 1.8 n.s. 0.2 n.s. 1.4 n.s. 24.1 <0.01**
6 S. De Santis et al. / Neuroscience xxx (2018) xxx–xxxDiﬀerences between NAWM and healthy control
tissue
All indices show signiﬁcant diﬀerences between NAWM
and the corresponding healthy tissue in the controlFig. 4. In the top row, microstructural parameter values for healthy controls v
ODI (d), FR from CHARMED (e) and FR from CHARMED measured with the h
for healthy controls vs MS in NAWM measured at 7 T: FA (g), MK (h), FR f
signiﬁcant diﬀerence in the nonparametric signed-rank test statistic (* = P<
a diﬀerent color. Abbreviations: FA = Fractional anisotropy; MK = Mean
dispersion and density imaging; ODI = Orientation Dispersion Index; CH
HC= Healthy controls; NAWM= Normal appearing white matter.
Please cite this article in press as: De Santis S et al. Characterizing Microstructural Tissue Properties in Multiple Sc
https://doi.org/10.1016/j.neuroscience.2018.03.048cohort at 3 T except ODI, while FA, ODI and FR from
CHARMED and FR from NODDI show signiﬁcant
diﬀerences at 7 T. The boxplots and the corresponding
nonparametric signed-rank test statistics are reported in
Fig. 4.s MS in NAWM measured at 3 T: FA (a), MK (b), FR from NODDI (c),
igh-b protocol (f). In the bottom row, microstructural parameter values
rom NODDI (i), ODI (j), FR from CHARMED (k). Asterisks represent
0.05, ** = P< 0.01). In (l), WM skeleton mask in which each ROI has
Kurtosis; FR = Restricted fraction; NODDI = Neurite orientation
ARMED= Composite hindered and restricted model of diﬀusion;
lerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
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tissue
In NAGM, MK, ODI, FR from NODDI and FR from
CHARMED at high-b show signiﬁcant diﬀerences
between healthy controls and MS at 3 T, while at 7 T
only FA, FR from NODDI and ODI show signiﬁcant
diﬀerences between the two cohorts. The boxplots and
the corresponding nonparametric signed-rank test
statistics are reported in Fig. 5.Eﬀect size
The eﬀect size, for all microstructural parameters and
across the tested protocols, for the combinations with
statistically signiﬁcant decrease according to the post
hoc test, is reported in Table 4. Notably, none of the
diﬀerences found in the ANOVA for FA survive the post
hoc t-test, while several microstructural indices show
signiﬁcant diﬀerences between healthy and MS cohort,
with eﬀect size up to 1.25. FR from CHARMED shows a
clear pattern of reduction in MS compared to controls,Fig. 5. In the top row, microstructural parameter values for healthy controls v
ODI (d), FR from CHARMED (e) and FR from CHARMED measured with the h
for healthy controls vs MS in NAGM measured at 7 T: FA (g), MK (h), FR f
signiﬁcant diﬀerence in the nonparametric signed-rank test statistic (** = P
diﬀerent color. Abbreviations: FA = Fractional anisotropy; MK= Mean Kurto
and density imaging; ODI = Orientation Dispersion Index; CHARMED= C
controls; NAGM= Normal appearing gray matter.
Table 4. Eﬀect size (Cohen’s d) of the diﬀerence between healthy control and M
all the microstructural parameters: FA, MK, FR from NODDI, ODI, FR from CH
Asterisks represent signiﬁcant diﬀerence in the Mann–Whitney test statistic (* =
MK=Mean Kurtosis; FR = Restricted fraction; NODDI = Neurite Orientation
CHARMED = Composite Hindered and Restricted Model of Diﬀusion; NAWM
matter
3 T
Lesions NAWM N
FA n.s. n.s. n.
MK 0.78 0.90 
FRNODDI 0.80 0.95 n.
ODI n.s. n.s. n.
FRCHARMED 0.74 0.95 n.
FRCHARMED HIGHB 0.60 n.s. 
Please cite this article in press as: De Santis S et al. Characterizing Microstructural Tissue Properties in Multiple Sc
https://doi.org/10.1016/j.neuroscience.2018.03.048both in lesions and NAWM, while no signiﬁcant
diﬀerences are found in NAGM. FR from NODDI shows
a similar pattern, except the diﬀerence in NAWM at 7 T
is not signiﬁcant. Also MK shows reduction in MS
compared to controls, in lesions, NAWM and NAGM at
3 T and only in lesions at 7 T. Notwithstanding the
decreasing trend observed in the boxplot for MS versus
controls, none of the signiﬁcant diﬀerence in ODI
survives post hoc t-test.DISCUSSION
In this work, we employed three diﬀerent multi-shell
diﬀusion MRI protocols at two ﬁeld strengths to measure
ﬁve microstructural MRI parameters from a range of
models (FA, MK, FRNODDI, ODI and FRCHARMED) in a
cohort of MS patients and a matched cohort of healthy
controls, with the aim of identifying the protocol and the
biomarker that best mirrors tissue diﬀerences in the
inﬂammatory lesions, in NAWM and NAGM compared to
healthy controls.s MS in NAGM measured at 3 T: FA (a), MK (b), FR from NODDI (c),
igh-b protocol (f). In the bottom row, microstructural parameter values
rom NODDI (i), ODI (j), FR from CHARMED (k). Asterisks represent
< 0.01). In (l), GM areas skeleton mask in which each ROI has a
sis; FR = Restricted fraction; NODDI = Neurite orientation dispersion
omposite hindered and restricted model of diﬀusion; HC = Healthy
S in lesions, NAWM and NAGM at both ﬁeld strengths (3 T and 7 T) for
ARMED and FR from CHARMED measured with the high-b protocol.
P< 0.05, ** = P< 0.01). Abbreviations: FA = Fractional anisotropy;
Dispersion and Density Imaging; ODI = Orientation Dispersion Index;
= Normal-appearing white matter; NAGM= Normal-appearing gray
7 T
AGM Lesions NAWM NAGM
s. n.s. n.s. n.s.
0.93 1.00 n.s. n.s.
s. 1.25 n.s. n.s.
s. n.s. n.s. n.s.
s. 0.64 0.67 n.s.
0.99 – – –
lerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
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a high-end set-up (De Santis et al., 2017), is that under
clinical settings more sophisticated microstructural mea-
sures (FRCHARMED, FRNODDI, and MK) are a better
descriptor than FA for the underlying tissue alterations
in both lesions and NAWM. The fact that FRCHARMED,
FRNODDI, and MK diﬀerences are signiﬁcant also in the rel-
atively small cohort analyzed in this study adds to the
translational potential of these multi-shell methods for
the clinical routine. Interestingly, while there are no major
diﬀerences between the performances of the low b-value
protocols across ﬁelds, our results suggest that the
short-time high b-value protocol is not optimal for
microstructural analysis in MS. Furthermore, we show
that a 10-min multi-shell diﬀusion protocol at 7 T has sim-
ilar performance in MS when compared to its counterpart
at 3 T, which is commonly considered the best option.
There are no diﬀerences in FRCHARMED between NAGM
and corresponding GM areas; this is expected as the
model is speciﬁcally formulated to account for the geom-
etry of WM.
FRNODDI gives similar results as FRCHARMED, although
the diﬀerences for FRNODDI in NAWM are not signiﬁcant at
7 T. ODI gives complementary information about the
neurite dispersion in both GM and WM and it has been
proposed as a novel tool to capture microstructural
changes in both NAWM and lesions in MS (Schneider
et al., 2017). Increased ODI in NAWM and decreased
ODI in lesions were reported in a small cohort
(Schneider et al., 2017), but another larger study found
no diﬀerences in normal-appearing tissue and an increase
in lesions (Granberg et al., 2017). Here, we found a trend
of reduced ODI in both MSWM and GM compared to con-
trols, which however is not statistically signiﬁcant. Taken
together, these results suggest that more studies with
larger cohorts are needed to characterize the ODI as a
putative marker for MS.
MK is reduced in MS compared to controls in lesions,
NAWM and NAGM at 3 T, and only in lesions at 7 T. The
reduction of MK in MS tissue compared to controls is in
agreement with recent work (Guglielmetti et al., 2016;
Qian et al., 2016). Recent ﬁndings (Chuhutin et al.,
2017) highlighted that precision and accuracy on MK
are highly dependent on the proper choice of b-values;
the ones employed in this study are optimal for WM, but
suboptimal for GM. Repeating the experiment using a
protocol with lower b-value might provide further insights
into the diﬀerences in kurtosis in NAGM compared to
controls.
The eﬀect size in lesions, as expected, is always
larger compared to NAWM and NAGM. Nonetheless,
most of the multi-shell microstructural parameters show
diﬀerences in NAWM, and some also in NAGM, while
FA does not capture signiﬁcant diﬀerences. While the
lack of results using conventional DTI might be certainly
due to the relatively small cohort employed in this study,
or to the choice of b-value, it is important to note that
multi-shell diﬀusion imaging has enough sensitivity to
highlight diﬀerences between healthy and lesioned
tissue also with low sample sizes, with huge potential
for the clinical routine.Please cite this article in press as: De Santis S et al. Characterizing Microstructural Tissue Properties in Multiple Sc
https://doi.org/10.1016/j.neuroscience.2018.03.048The main diﬀerences between the diﬀerent tested
protocols are: (1) the SNR of the images, aﬀected by
both the ﬁeld magnitude and the echo time; (2) the
diﬀusion contrast, which depends on the applied b-
value; and (3) the echo time, which can change the
proportion between tissue compartments with diﬀerent
T2 relaxation times (De Santis et al., 2016).
There are diﬀerences between the SNRs across
protocols, but these do not fully explain the results
obtained: for example, the 3 T/high-b protocol does not
have the lowest SNR, but showed the worst
performance in detecting lesions and NAWM changes
compared to the other protocols for FRCHARMED.
Moreover, when SNR is used as covariate in the
ANOVA, the eﬀect of the protocol is still signiﬁcant for
both FA, FRNODDI and FRCHARMED. Atrophy,
demyelination and brain lesions can have an impact on
the SNR, because they lead to changes in intensities
and contrast, but the SNR was not diﬀerent between the
MS and control groups in any of the investigated
protocols. The 3 T/low-b and 7 T/low-b protocols
implemented in this study have the same b-value and
similar timing in the diﬀusion sequence, implying similar
diﬀusion and T2 weighting; on the other hand, the 3 T/
high-b sequence, having a larger maximum b-value and
larger TE, also corresponds to diﬀerent diﬀusion and T2
weighting. The characteristics of the applied gradients
inﬂuence the sensitivity of the sequence to diﬀerent
compartments; while normally high b-values are
considered beneﬁcial, for example, to increase the
power to resolve ﬁber crossing (Cohen-Adad et al.,
2011; De Santis et al., 2014), the results obtained here
suggest that in the context of early-stage MS they may
not be the best choice. We speculate that this might
depend on inﬂammation-related diﬀerences in the T2
relaxation time between normal and damaged tissue
(van Waesberghe et al., 1999), given that a long echo
time (required for high b-values on clinical gradients)
changes the proportion between tissue compartments
with diﬀerent T2 relaxation times (De Santis et al.,
2016). The situation can be diﬀerent for more advanced
conﬁgurations, like gradients with intensity even higher
than 70–80 mT/m, which achieve a TE reduction for high
b-values, for long-time protocols, or for further advances
which signiﬁcantly increase the speed of imaging. Our
results also suggest that the high b-value protocol can
be useful when looking at GM.
Importantly, our ﬁndings support the feasibility of
CHARMED, NODDI and DKI at 7 T. With the numerous
further advantages in other (e.g., functional) MRI
imaging contrasts, ultra-high ﬁeld is rapidly emerging as
the high-end instrument for neuroimaging. 7 T is
sometimes considered to be of limited beneﬁt for
diﬀusion, but recent studies demonstrated that SNR
diﬀerences across similar diﬀusion protocols at 3 T and
7 T are minimal (Wen et al., 2015), and that 7 T can even
be advantageous when high gradient intensity (i.e., >70
mT/m) is available (Ug˘urbil et al., 2013). The results
presented here might also contribute to explaining the
discrepancy in the ﬁndings of diﬀerent diﬀusion MRI
studies in MS, which can be at least partially attributedlerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design. Neuroscience (2018),
S. De Santis et al. / Neuroscience xxx (2018) xxx–xxx 9to diﬀerences in the protocols used, and lay the ground for
the standardization of diﬀusion protocols in MS.CONCLUSIONS
Multi-shell diﬀusion acquisitions increased the ability to
detect axonal pathology occurring in MS brain tissue
compared to conventional DTI in a small pilot study,
also under clinical settings. In addition, our ﬁndings
suggest that multi-shell diﬀusion MRI at both high (3 T)
and ultra-high ﬁelds (7 T) are viable options for imaging
tissue change in MS lesions and normal appearing WM,
while higher b-values are not beneﬁcial for MS under
the tested short-time (10 min acquisition) conditions.ACKNOWLEDGEMENTS
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